Prashant Nair, Ariel Roguin, 208
“Magnetic Resonance Imaging in patients with ICDs and Pacemakers”
cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in
vivo assessment of safety and function at 1.5 T. Circulation. 2004;110:475-82.
27. Schmiedel A, Hackenbroch M, Yang A, Nahle CP, Skowasch D, Meyer C, Schimpf R, Schild
H, Sommer T. Magnetic resonance imaging of the brain in patients with cardiac pace makers. In-
vitro- and in-vivo-evaluation at 1.5 Tesla. Rofo. 2005; 177:731-44.
28. Luechinger R, Zeijlemaker VA, Pedersen EM, Mortensen P, Falk E, Duru F, Candinas R,
Boesiger P. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J.
2005;26:376-83.
29. Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of
a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol.
2001;24:199-205.
30. Pohost GM, Blackwell GG, Shellock FG. Safety of patients with medical devices during
application of magnetic resonance methods. In Richard L. Magin, Robert P. Liburdy, and Bertil
Persson editors, Biological effects and safety aspects of nuclear magnetic resonance imaging and
spectroscopy, volume 649 of Annals of the New York Academy of Science, pages 302-312.
New York Academy of Sciences, March 1992.
31. Vahlhaus C, Sommer T, Lewalter T, Schimpf R, Schumacher B, Jung W, Luderitz
B.Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible
changes at 0.5 Tesla? Pacing Clin Electrophysiol. 2001;24:489-95.
32. Martin ET ,Coman JA, Shellock FG ,Pulling CC, Fair R ,Jenkins K: Magnetic resonance
imaging and cardiac pacemaker safety at 1.5- Tesla :J Am Coll Cardiol.2004;43:1315-1324.
33. Gimbel JR, Johnson D, Levine PA, Wilkoff BL: Safe performance of magnetic resonance
imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol.
1996;19:913-9.
34. Peden CJ, Collins AG, Butson PC, Whitwam JG, Young IR. Induction of microcurrents in
critically ill patients in magnetic resonance systems. Crit Care Med, 1993; 21:1923-1928.
35. Hartnell GG, Spence L, Hughes LA, Cohen MC, Saouaf R, Buff B. Safety of MR imaging in
patients who have retained metallic materials after cardiac surgery. AJR 1997, 168:1157-1159.
36. Kanal E. Safety of MR imaging in patients with retained epicardial pacer wires (letter). AJR
1998; 170:213.
37. Gimbel JR, Trohman RL, Lindsay WC, et al. Strategies for the safe performance of magnetic
resonance imaging in selected ICD patients. PACE 2002;25:618.
38. Anfinsen O, Berntsen RF, Aass H, et al. Implantable cardioverter defibrillator dysfunction
during and after magnetic resonance imaging. Pacing Clin Electrophysiol 2002; 25:1400-1402.
39. Fiek M, Remp T, Reithmann C, Steinbeck G. Complete loss of ICD programmability after
magnetic resonance imaging. Pacing Clin Electrophysiol 2000; 27:1002-4.
40. Coman JA, Martin ET, Sandler DA, et al. Implantable cardiac defibrillator interactions with
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 5(3): 197-209 (2005)